drugset / Trial / NCT01759238
Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study tries to evaluate the role of chemoradiation with capecitabine and bevacizumab in oligometastatic patients neither being progressive nor resectable after chemotherapy.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-10
- Completion
- 2014-10
Outcome
Outcome not reported
Stopped (Enrollment): “unexpectedly slow recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 7.5 mg/kg | — |
| Subject | Capecitabine | Small molecule | 825 mg/m2 | Oral |